Trial Profile
Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Pirarubicin (Primary) ; Epirubicin
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 18 Nov 2015 New trial record